OpenBilldrug price receipt

NADAC week of 2026-10-14

MESALAMINE 1,000 MG SUPP

For 1 suppository

Pharmacies pay

$1.28 filed

1 × $1.28382 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$6.47 estimated

$1.28 + $0.19 (15%) + $5.00 fee per fill = $6.47

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

MESALAMINE 1,000 MG SUPP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as mesalamine, under the trade name “Mesalamine Rectal”.

FDA gives its dosage form as suppository and its route as rectal.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Rising Pharma Holdings, Inc. and Northstar Rx LLC.

FDA’s Established Pharmacologic Class for it is Aminosalicylate.

The NADAC file of 2026-10-14 prices it under 12 NDCs (National Drug Codes); the FDA directory lists 7 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.28 for 1 suppository (1 × $1.28382 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 6 labelers

LabelerNDCsPharmacies pay per unit
Rising Pharma Holdings, Inc.2$1.28382 per EA filed
Actavis Pharma, Inc.1$1.28382 per EA filed
Amring Pharmaceuticals Inc.1$1.28382 per EA filed
Camber Pharmaceuticals, Inc.1$1.28382 per EA filed
Northstar Rx LLC.1$1.28382 per EA filed
Zydus Pharmaceuticals USA Inc.1$1.28382 per EA filed
Not listed as a package in the FDA directory5$1.28382 per EA filed
All 12 NDCs, with labeler and price
  • 00472-1915-01 · not listed as a package in the FDA directory · $1.28382 per EA · eff. 2026-09-23 filed
  • 00472-1915-30 · Actavis Pharma, Inc. · $1.28382 per EA · eff. 2026-09-23 filed
  • 16571-0246-03 · Rising Pharma Holdings, Inc. · $1.28382 per EA · eff. 2026-09-23 filed
  • 16571-0246-16 · not listed as a package in the FDA directory · $1.28382 per EA · eff. 2026-09-23 filed
  • 16714-0245-01 · not listed as a package in the FDA directory · $1.28382 per EA · eff. 2026-09-23 filed
  • 16714-0245-30 · Northstar Rx LLC. · $1.28382 per EA · eff. 2026-09-23 filed
  • 31722-0005-30 · Camber Pharmaceuticals, Inc. · $1.28382 per EA · eff. 2026-09-23 filed
  • 31722-0005-32 · not listed as a package in the FDA directory · $1.28382 per EA · eff. 2026-09-23 filed
  • 64980-0282-03 · Rising Pharma Holdings, Inc. · $1.28382 per EA · eff. 2026-09-23 filed
  • 69918-0560-30 · Amring Pharmaceuticals Inc. · $1.28382 per EA · eff. 2026-09-23 filed
  • 70710-1302-06 · not listed as a package in the FDA directory · $1.28382 per EA · eff. 2026-09-23 filed
  • 70710-1302-07 · Zydus Pharmaceuticals USA Inc. · $1.28382 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

10 other products in the NADAC file share the FDA nonproprietary name mesalamine with MESALAMINE 1,000 MG SUPP.

ProductPharmacies pay per unitMedicare per unit
CANASA 1,000 MG SUPPOSITORY
brand · suppository
$37.10967 per EA filed
eff. 2026-09-23
$36.05608 per EA filed
Part D 2024 average
LIALDA DR 1.2 GM TABLET
brand · tablet, delayed release
$8.94652 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 1,000 MG SUPP this page
generic · suppository
$1.28382 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 4 GM/60 ML ENEMA
generic · suspension / enema
$0.09843 to $0.17585 per ML filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 4 GM/60 ML KIT
generic · kit
$134.90444 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 800 MG DR TABLET
generic · tablet, delayed release
$4.02045 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE DR 1.2 GM TABLET
generic · tablet, delayed release
$0.7809 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE DR 400 MG CAPSULE
generic · capsule, delayed release
$2.69898 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE ER 0.375 GRAM CAP
generic · capsule, extended release
$0.47798 per EA filed
eff. 2026-09-23
$1.37992 per EA filed
Part D 2024 average
PENTASA 250 MG CAPSULE
brand · capsule
$2.90086 per EA filed
eff. 2026-09-23
$5.03307 per EA filed
Part D 2024 average
PENTASA 500 MG CAPSULE
brand · capsule
$5.82619 per EA filed
eff. 2026-09-23
$5.03307 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 12 NDCs’ NADAC prices is $1.28382 per EA filed.

Of the 12 other products in FDA’s Aminosalicylate class priced per EA, 7 have a higher middle NADAC price and 5 a lower one. The one in the middle is MESALAMINE DR 400 MG CAPSULE, at $2.69898 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 suppository?
NADAC prices this product per EA, and the FDA NDC Directory lists 7 of its 12 NDCs (it does not list the other 5) as dosage form “SUPPOSITORY” with route “RECTAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. So the card starts at 1 suppository, priced per suppository, rather than guess how many make up a fill; change it to match your prescription.